Therefore, by concurrently addressing both hyperglycemia and insulin resistance, combination therapy with hydrocortisone and insulin may offer synergistic effects in improving glycemic control and ameliorating the metabolic derangements associated with DS [11]. Here, INS is linked to Dravet syndrome.